Replacement vs Fixation for Distal Femur Fractures
(pDIFFIR Trial)
Trial Summary
What is the purpose of this trial?
Periprosthetic distal femur fractures are a significant source of morbidity and mortality for elderly patients. One treatment option involved a surgical fixation with plates or nails, screws and cables/wires along the side of your fractured bone. The second method consists in replacing your knee joint with an artificial knee prosthesis (artificial knee joint). The primary objective is to determine if acute distal femur replacement improves knee pain and functional outcomes compared to surgical fixation. Secondary outcomes are mortality, reoperation, complications, post-operative pain and quality of life. A health economic analysis will be conducted to assess the cost-effectiveness of both treatments. A total of 148 patients (74/group) will be enrolled in the study.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment for distal femur fractures?
Research comparing distal femoral replacement (DFR) and open reduction internal fixation (ORIF) for distal femur fractures suggests that both treatments are used, but there is limited data directly comparing their outcomes. Some studies focus on factors like implant survivorship and functional recovery, indicating that both methods have been effective in different scenarios.12345
Is distal femur replacement or fixation generally safe for humans?
Research shows that both distal femur replacement and surgical fixation have been used safely in humans for treating fractures around the knee, with studies comparing their complication rates. While specific safety data for other conditions isn't detailed, these treatments are generally considered safe for managing fractures.12356
How does the treatment for distal femur fractures differ from other treatments?
Distal femur replacement (DFR) is unique because it involves replacing the damaged part of the femur with an artificial joint, which can allow for earlier mobilization compared to open reduction and internal fixation (ORIF), where the bone is repaired using metal plates and screws. This approach may be particularly beneficial for older patients or those with complex fractures.12357
Research Team
Jesse I Wolfstadt, MD
Principal Investigator
Mount Sinai Health Hospital
Amir Khoshbin, MD
Principal Investigator
Unity Health Toronto - St Michael's Hospital
Eligibility Criteria
This trial is for individuals aged 65 or older who have a specific type of knee fracture (periprosthetic distal femur fracture) around a stable knee replacement. Candidates must have been able to walk before the injury, even if they needed help, and not be severely frail. They should understand the consent form or have an interpreter available.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either surgical fixation or distal femur replacement
Follow-up
Participants are monitored for knee function, mortality, and other outcomes
Treatment Details
Interventions
- Distal Femur Replacement
- Surgical fixation
Distal Femur Replacement is already approved in European Union, United States, Canada for the following indications:
- Periprosthetic distal femur fractures
- Geriatric distal femur fractures
- Periprosthetic distal femur fractures
- Geriatric distal femur fractures
- Periprosthetic distal femur fractures
- Geriatric distal femur fractures
Find a Clinic Near You
Who Is Running the Clinical Trial?
Unity Health Toronto
Lead Sponsor
Mount Sinai Hospital, Canada
Collaborator